Syndax Pharmaceuticals, Inc. (SNDX)
20.68
-0.10
(-0.48%)
USD |
NASDAQ |
Sep 03, 16:00
Syndax Pharmaceuticals Net Income (Annual) : -285.42M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -285.42M |
| December 31, 2024 | -318.76M |
| December 31, 2023 | -209.36M |
| December 31, 2022 | -149.34M |
| December 31, 2021 | 24.93M |
| December 31, 2020 | -77.06M |
| December 31, 2019 | -56.05M |
| December 31, 2018 | -73.96M |
| Date | Value |
|---|---|
| December 31, 2017 | -60.80M |
| December 31, 2016 | -44.47M |
| December 31, 2015 | -24.12M |
| December 31, 2014 | -19.83M |
| December 31, 2013 | -60.45M |
| December 31, 2012 | -9.965M |
| December 31, 2011 | -13.09M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Viking Therapeutics, Inc. | -359.64M |
| Kura Oncology, Inc. | -278.67M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |